Logothetis CJ - Search Results

1

Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways.

Dayyani F, Parikh NU, Varkaris AS, Song JH, Moorthy S, Chatterji T, Maity SN, Wolfe AR, Carboni JM, Gottardis MM, Logothetis CJ, Gallick GE. Dayyani F, et al. Among authors: logothetis cj. PLoS One. 2012;7(12):e51189. doi: 10.1371/journal.pone.0051189. Epub 2012 Dec 26. PLoS One. 2012. PMID: 23300537 Free PMC article.

2

Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancer.

Sella A, Aggarwal BB, Kilbourn RG, Bui CA, Zukiwski AA, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. Cancer Biother. 1995 Fall;10(3):225-35. doi: 10.1089/cbr.1995.10.225. Cancer Biother. 1995. PMID: 8547961 Clinical Trial.

3

TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.

Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ. Navone NM, et al. Among authors: logothetis cj. Clin Cancer Res. 2000 Mar;6(3):1190-7. Clin Cancer Res. 2000. PMID: 10741751

4

Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts.

Newman RA, Yang J, Raymond M, Finlay V, Cabral F, Vourloumis D, Stephens LC, Troncoso P, Wu X, Logothetis CJ, Nicolaou KC, Navone NM. Newman RA, et al. Among authors: logothetis cj. Cancer Chemother Pharmacol. 2001 Oct;48(4):319-26. doi: 10.1007/s002800100323. Cancer Chemother Pharmacol. 2001. PMID: 11710633

5

Osteoblasts in prostate cancer metastasis to bone.

Logothetis CJ, Lin SH. Logothetis CJ, et al. Nat Rev Cancer. 2005 Jan;5(1):21-8. doi: 10.1038/nrc1528. Nat Rev Cancer. 2005. PMID: 15630412 Review.

6

Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.

Li ZG, Yang J, Vazquez ES, Rose D, Vakar-Lopez F, Mathew P, Lopez A, Logothetis CJ, Lin SH, Navone NM. Li ZG, et al. Among authors: logothetis cj. Oncogene. 2008 Jan 24;27(5):596-603. doi: 10.1038/sj.onc.1210694. Epub 2007 Aug 13. Oncogene. 2008. PMID: 17700537

7

Understanding the biology of bone metastases: key to the effective treatment of prostate cancer.

Logothetis CJ, Navone NM, Lin SH. Logothetis CJ, et al. Clin Cancer Res. 2008 Mar 15;14(6):1599-602. doi: 10.1158/1078-0432.CCR-07-4603. Clin Cancer Res. 2008. PMID: 18347159 Review.

8

Strategy for the application of therapy in prostate cancer.

Logothetis CJ. Logothetis CJ. Adv Exp Med Biol. 2008;617:193-9. doi: 10.1007/978-0-387-69080-3_18. Adv Exp Med Biol. 2008. PMID: 18497043 Review. No abstract available.

9

Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.

Li ZG, Mathew P, Yang J, Starbuck MW, Zurita AJ, Liu J, Sikes C, Multani AS, Efstathiou E, Lopez A, Wang J, Fanning TV, Prieto VG, Kundra V, Vazquez ES, Troncoso P, Raymond AK, Logothetis CJ, Lin SH, Maity S, Navone NM. Li ZG, et al. Among authors: logothetis cj. J Clin Invest. 2008 Aug;118(8):2697-710. doi: 10.1172/JCI33093. J Clin Invest. 2008. PMID: 18618013 Free PMC article.

10

GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example.

Gorlov IP, Gallick GE, Gorlova OY, Amos C, Logothetis CJ. Gorlov IP, et al. Among authors: logothetis cj. PLoS One. 2009 Aug 4;4(8):e6511. doi: 10.1371/journal.pone.0006511. PLoS One. 2009. PMID: 19652704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

414 results

Search Page